We are advised by YS Biopharma Co., Ltd. (NASDAQ:YS) that journalists and other readers should disregard the news release, “YS Biopharma Co., Ltd. to Hold Extraordinary General Meeting on December 28, 2023“, issued on December 20, 2023 by YS Biopharma over PR Newswire, as the release contained erroneous information.